Sale of Receivables	9 Months Ended
Sale of Receivables	Dec. 30, 2016
Transfers and Servicing [Abstract]
Sale of Receivables	Sale of Receivables On December 21, 2016, the Company established a $250 million accounts receivable securitization facility (the Receivables Facility) with certain unaffiliated financial institutions (the Purchasers). Under the Receivables Facility, the Company and certain of its subsidiaries sell billed and unbilled accounts receivable to CSC Receivables, LLC (CSC Receivables), a wholly owned bankruptcy-remote entity. CSC Receivables in turn sells such purchased accounts receivable in their entirety to the Purchasers pursuant to a receivables purchase agreement. Sales of receivables by CSC Receivables occur continuously and are settled on a monthly basis. The proceeds from the sale of these receivables comprise a combination of cash and a deferred purchase price receivable (DPP). The DPP is realized by the Company upon the ultimate collection of the underlying receivables sold to the Purchasers. The amount available under the Receivables Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business after deducting excess concentrations. As of December 30, 2016, the total availability under the Receivables Facility was approximately $224 million. The Receivables Facility terminates on December 20, 2017, but may be extended. The Company expects to use the proceeds from receivables sales under the Receivables Facility for general corporate purposes. The Company accounts for receivables sold under the Receivables Facility as a sale of financial assets pursuant to ASC 860 “Transfers and Servicing” and derecognizes these receivables, as well as the related allowances, from its Condensed Consolidated Balance Sheets. The Company has no retained interests in the transferred receivables, other than collection and administrative services and its right to the DPP. The Company carries the DPP at fair value determined by calculating the expected amount of cash to be received and is principally based on unobservable inputs consisting primarily of the face amount of the receivables adjusted for anticipated credit losses (see Note 7 - Fair Value). The DPP is included in receivables, net of allowance for doubtful accounts on the unaudited Condensed Consolidated Balance Sheets. The fair value of the sold receivables approximated their book value due to their short-term nature, and as a result no gain or loss on sale of receivables was recorded. In exchange for the sale of accounts receivable as of December 30, 2016, the Company received cash of $241 million and recorded a DPP. The DPP, which fluctuates over time based on amounts of new receivables sold and cash collections, was $311 million as of December 30, 2016. Additionally, as of December 30, 2016, the Company recorded a $17 million liability within accounts payable because the amount of cash proceeds received by the Company under the Receivables Facility exceeded the maximum funding limit. CSC pays a fee at each monthly settlement date for the drawn and undrawn portions of the Receivables Facility, which is classified as selling, general and administrative expense in the unaudited Condensed Consolidated Statement of Operations. Due to the short duration that the Receivables Facility was available during the three months ended December 30, 2016, no expense has been recognized related to the fee. The Company reflects all cash flows related to the Receivables Facility as operating activities in its Condensed Consolidated Statements of Cash Flows because the cash received from the Purchasers upon both the sale and collection of the receivables is not subject to significant interest rate risk given the short-term nature of the Company’s trade receivables. The Company’s risk of loss following the transfer of accounts receivable under the Receivables Facility is limited to the DPP outstanding and any short-falls in collections for specified non-credit related reasons after sale. Payment of the DPP is not subject to significant risks other than delinquencies and credit losses on accounts receivable sold under the Receivables Facility. The receivable securitization program agreements contain certain customary representations and warranties and affirmative covenants, including as to the eligibility of the receivables being sold and contain customary program termination events and non-reinvestment events. CSC was in compliance with all covenants associated with its Receivables Facility as of December 30, 2016.

The entire disclosure for a transferor's continuing involvement in financial assets that it has transferred in a securitization or asset-backed financing arrangement, the nature of any restrictions on assets reported by an entity in its statement of financial position that relate to a transferred financial asset (including the carrying amounts of such assets), how servicing assets and servicing liabilities are reported, and (for securitization or asset-backed financing arrangements accounted for as sales) when a transferor has continuing involvement with the transferred financial assets and transfers of financial assets accounted for as secured borrowings, how the transfer of financial assets affects an entity's financial position, financial performance, and cash flows.